The tweet was deleted by the author.
But we saved everything 🙂.
Kura Oncology has appointed Jennifer Fulk as its new chief financial officer.
The company said Fulk brings over 20 years of financial and operational leadership experience from the biopharmaceutical industry, including expertise across commercial finance and research and development portfolio management. The appointment marks a key leadership addition for Kura Oncology as it continues its activities in the sector.
View post on X Loading...
Kura Oncology recently participated in three major investor conferences in September, including those organized by Wells Fargo and Cantor Fitzgerald, according to a previous company statement. The company has also highlighted its unique culture, citing its global team as central to its scientific progress in an earlier report. These developments come as leadership changes continue at the firm.